Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
GSK Supply Status
Please note: this page is updated weekly. If a product is not listed below, GSK are not experiencing supply constraints. Please contact your wholesaler
Product name |
PIP Code |
Status |
Estimated recovery date |
|---|---|---|---|
| AUGMENTIN SUSP 250/62.5MG/5ML 1X100ML_UK | 823609 | OUT OF STOCK | LATE JULY 2025 |
| BETNOVATE RD OINT 0.025% 100G UK-GSK | 485227 | OUT OF STOCK | LATE JULY 2025 |
| CUTIVATE OINT 0.005% 30G X 1 TUBE UK-GSK | 3470093 | OUT OF STOCK | LATE JULY 2025 |
| DERMOVATE SCALP APPLICATION 1X30ML | 267302 | OUT OF STOCK | EARLY AUGUST 2025 |
| IMIGRAN N.S. 20X6 CP UK | 2330728 | OUT OF STOCK | LATE JULY 2025 |
| REQUIP TAB 0.25MG 1X21_GB | 3940277 | OUT OF STOCK | LATE JULY 2025 |
| WELLVONE ORAL SUSPENSION 750MG/5ML - UK | 2442226 | OUT OF STOCK | LATE JULY 2025 |
| VALTREX TAB 250MG 6X10_GB | 3229895 | OUT OF STOCK | EARLY OCTOBER 2025 |
| VALTREX TAB 500MG 1X10_GB | 2256428 | OUT OF STOCK | EARLY OCTOBER 2025 |
| VALTREX TABLET 500MG 3X14_GB | 2155075 | OUT OF STOCK | EARLY SEPTEMBER 2025 |
Product name |
PIP Code |
Status |
Estimated recovery date |
|---|
If you have any queries about the availability of a product, please contact your wholesaler.
3rd Party Distribution
From 1st Sept 2023, GSK and Recordati have agreed a deal whereby RECORDATI PHARMACEUTICALS LIMITED will take over the Distribution and Commercial activities for the following products.
Product name |
PIP Code |
|---|---|
| AVODART Capsules 0.5mg x 30 | 2921070 |
| COMBODART Capsules 0.5mg/0.4mg x 30 | 3542560 |
Orders can be placed at this email address:
Further information
If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com).
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com
